Linker Payload Design & Synthesis

Accelerating and de-risking the development and manufacture of your next-generation therapies, our integrated approach supports the lifecycle of antibody-drug conjugate (ADC) discovery and development including the design and synthesis of payload-linker constructs for ADCs and conjugates.

Offering a comprehensive approach, we use a matrix evaluation and developability approach to streamline the development, scale, and manufacture of your challenging payloads, linkers and payload-linker chemical intermediates for ADCs and other conjugates for your discovery and preclinical programs.